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1. Introduction
   Malaria remains a serious health problem in sub-
Saharan Africa, tropical and many sub-tropical regions in 
the world. In 2011, about 3.3 billion people globally were 
at risk of malaria and approximately 90% of people who 
die from the disease reside in the WHO African region[1]. 
Plasmodium falciparum (P. falciparum) causes the most 
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Objective: To evaluate the antiplasmodial properties of fractions of chloroform portion of 
Phyllanthus niruri (P. niruri) methanol extract and identify a suitable chemical marker present 
therein. 
Methods: Chloroform portion of P. niruri methanol extract was separated from silica gel 
using gradient systems of hexane, ethylacetate and methanol. The fractions were screened for 
antiplasmodial activity against Plasmodium falciparum HB3 and FcM29. Fractions with IC50<10 
µg/mL against parasites were further screened for peripheral analgesic activity, while cytotoxicity 
was evaluated using THP-1 cells. 
Results: Fractions 12-14 were very active (IC50<10 µg/mL) against Plasmodium falciparum and 
showed no significant cytotoxicity. Fractions 12 and 13 exhibited significant (P<0.01) reduction 
in acetic acid-induced writhing in mice, decreasing the number of writhes by 66.67% and 65.22% 
respectively and comparable with 100 mg/kg aspirin (65.22%). From fraction 12, a compound was 
isolated and identified as sitosteryl-6-β-D-glucoside-6’-palmitate by 1H, 13C nuclear magnetic 
resonance and mass spectroscopies. 
Conclusions: Our findings illustrate antiplasmodial column fractions of P. niruri with analgesic 
activity and identify sitosteryl glucoside palmitate as a chemical marker of activity.
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lethal forms of malaria: cerebral malaria and severe malaria 
anaemia which account for most malaria-associated 
mortalities, especially in children less than five years 
old[2]. Chloroquine- and multidrug-resistant P. falciparum 
strains now prevail in malaria-endemic areas with high 
transmission rates; thus, artemisinin based combination 
therapies (ACT) for treating malaria in these areas are used. 
Even so, inaccessibility and high costs of the drugs hinder 
the use of ACTs and evidence suggests that the parasite 
has developed resistance to ACTs in certain areas, which 
implies the possibility of a rise in recrudescent disease and 
mortalities[3,4]. With few alternative antimalarial regimens, 
the search for new options that are safe, effective and 
affordable remains a priority. In most cases, plants have 
been investigated as sources of new leads as they show 
enormous potential. According to the identification of 
artemisinin, quinine and other antimalarial pharmacophores 
come from different plants[5-8]. The herb, Phyllanthus 
niruri (P. niruri) (family: Euphorbiaceae) is widely used as 
medicine in nearly all tropical countries where it is found. 
Decoctions of aerial parts of the plant are employed as 
a remedy for fever, diabetes, liver and kidney ailments. 
Previous investigations show its useful pharmacological 
properties[9-12]. Different investigators have also reported 
the antiplasmodial actions of P. niruri extracts[13-15]. 
From the boiled aqueous extract of P. niruri, four known 
compounds with antiplasmodial activity were isolated[13]. 
However, Sholikhah et al. described the methanol extract 
of P. niruri as the most active extract, compared with the 
aqueous and chloroform extract[14]. Similarly, our earlier 
investigation of P. niruri methanol extract also showed that 
the chloroform portion of the extract was more effective 
against Plasmodium berghei in early infection than its 
ethanol and aqueous portions in mice[15]. The present study 
was carried out to determine active fractions of the organic 
chloroform fraction and identify compounds therein by 
antiplasmodial activity-guided fractionation, using in vitro 
antiplasmodial activity against chloroquine-sensitive and 
chloroquine-resistant P. falciparum as bio-activity guide.
2. Materials and methods 
2.1. Parasite strain and THP-1 cell line
   Chloroquine-sensitive Plasmodium berghei (NK 65 
strain) was sourced from the National Institute for Medical 
Research, Lagos, Nigeria. The parasite was maintained in 
the Department of Pharmacology and Toxicology, National 
Institute for Pharmaceutical Research and Development 
(NIPRD) by continuous reinfection by intraperitoneal passage 
in mice.
   Chloroquine-sensitive (HB3) and chloroquine-resistant 
(FcM29) P. falciparum strains were obtained from Centre 
National d’Application des Recherches Pharmaceutiques, 
Madagascar. THP-1 cell line was obtained from the National 
Centre for Cell Science, Pune, India.
2.2. Animals
   Adult albino Wistar rats of either sex weighing 100-150 g 
were used. Prior to the study, the rats were acclimatized 
to laboratory conditions in the animal facility centre in 
NIPRD. They were housed in stainless steel cages, fed with 
standard rodent diet and allowed free access to potable 
drinking water. All animal experiments were carried out in 
accordance with NIPRD standard operating procedures and 
the updated National Institutes of Health guideline for the 
care and use of laboratory animals[16].
2.3. Drugs and chemicals
   Chloroquine, artemisinin, acetylsalicylic acid (ASA), acetic 
acid, chloroform and ethylacetate purchased from Sigma 
Aldrich (St Louis MO, USA) and quinine dihydrate (Acros 
organics NJ, USA) were used. Other reagents used were of 
analytical grade.
2.4. Plant material, extraction and fractionation     
   Fresh aerial parts of P. niruri were collected from Orba, 
Enugu State, Nigeria on 25 July 2011. A voucher specimen 
was prepared and deposited in NIPRD herbarium (NIPRD/
H/6565). The roots of the plant were cut off and the aerial 
parts dried at room temperature for two weeks then 
pulverized to coarse powder using an electric hammer mill.
   The powdered plant material (2.03 kg) was extracted 
with 10 L methanol (98% v/v) for 48 h with occasional 
mechanical shaking (4 h/day) and afterwards, the mixture 
was filtered using ashless filter paper. The filtrate was 
concentrated under reduced pressure using a rotary 
evaporator to give 100 g of the methanol extract. The extract 
was portioned between water and chloroform (4伊600 mL) 
using a separatory funnel. The combined lower chloroform 
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layer was concentrated to dryness under vacuum by rotary 
evaporation at 40 °C and the slurry obtained was designated 
F1 (35 g).  
   F1 was further separated by column chromatography 
(CC) over silica gel (100-200 mesh size) and eluted with 
n-hexane first, then successively in a gradient manner with 
n-hexane: ethylacetate, ethylacetate: methanol and finally 
with methanol. Eluates that showed similar thin layer 
chromatography (TLC) profiles were pooled together to afford 
15 fractions labelled 1-15. The fractions were concentrated 
by rotary evaporation under vacuum. Solvent-free fractions 
were stored in screw-cap glass bottles in a refrigerator until 
required in the experiments.
2.5. Antiplasmodial assay
2.5.1. In vitro parasite culture
   Chloroquine-sensitive (HB3) and chloroquine-resistant 
(FcM29) P. falciparum strains were maintained in culture 
according to the modified method of Trager and Jensen[17]. 
The parasites were cultured in human erythrocytes (blood 
group AB) in complete media, comprising RPMI 1640 medium 
supplemented with 10% heat inactivated human blood type 
O+ serum, 25 mmol/L HEPES, 25 mmol/L gentamycin and 
NaHCO3. Prior to assay, infected red blood cells were washed 
thrice in incomplete media (without serum). Parasitaemia 
was determined by light microscopy from thin smears 
that were fixed in absolute methanol, blotted dry and 
stained with commercial Romanowski stain (Diff-Quik). 
Only cultures with 7%-10% parasitaemia were adjusted 
accordingly and used for the assay. 
2.5.2. Estimation of parasite growth inhibition
   This assay was performed as described previously[18]. 
Briefly, stock solutions of fractions 1-15 were made by 
dissolving known quantities in dimethylsulfoxide (DMSO). 
Stock solutions was serially double diluted using RPMI 
1640 (incomplete media) as diluent in 96 well round bottom 
microplates, test concentrations ranged from 0.39-50 µg/
mL. Chloroquine, artemisinin and quinine were used as 
reference drugs, assay was done in duplicate for each 
concentration used. From each dilution, 50 µL volumes was 
transferred to wells in a flat bottom plate each containing 
50 µL incomplete media before the addition of 100 µL of 
infected red blood cells (adjusted to 1% parasitaemia and 2% 
haematocrit in complete media) to give a final volume of 200 
µL per well. The plates were incubated in 95% CO2 at 37 
o
C 
for 72 h for parasite growth. After 72 h, parasite growth was 
determined using a SYBR Green I-based assay. 
   The concentration of the test fraction/drug that produced 
50% inhibition of parasite growth (IC50) was determined 
graphically, from a plot of the relative growth versus the 
concentrations of the fraction/drug; where 
Relative growth= (parasitaemia (%) in treated well/maximum 
parasitaemia (%) in untreated wells)伊100%.
2.6. THP-1 cytotoxicity assay
   This was done according to the method described 
by Ezenyi et al[18]. Briefly, cells were grown in Eagle’s 
minimum essential medium (MEM; GIBCO, NY, USA) 
supplemented with 10% fetal bovine serum in 25-mL cell-
culture flasks incubated at 37 oC in 5% CO2. About 100 µL 
of cell culture (cell density of about 107) was seeded at 
an approximate concentration 104 cells/mL in minimum 
essential medium and 10% fetal bovine serum containing 
100 µg/mL of streptomycin and ampicillin respectively in 
a sterile 96-well plate. Stock sample solutions of fractions 
12, 13 and 14 (10 mg/mL each) were prepared in DMSO 
(Sigma Chemical Co., St. Louis, MO) and 1 µL (100 µg/mL) 
was added in triplicate to test wells. Blank wells contained 
culture media in place of cell culture while control wells 
contained DMSO instead of the sample solution. The plates 
were incubated at 37 oC for 72 h and on the 4th day, 10 µL 
of 3-(4, 5-dimethylthiazol-2-yl)-2, 5-diphenyl tetrazolium 
bromide dye solution (5 mg/mL) was added to each well and 
further incubated for 1 h. After 4 h, 200 µL isopropanol was 
added to the culture and absorbance was read at 490 nm.
2.7. Effect of active fractions on acetic acid-induced 
abdominal writhing test in rats
   Fractions 12, 13, 14 that exhibited high antiplasmodial 
activity were further screened for antinociceptive activity. 
The method of Tajik et al. was adopted with minor 
modification[19]. Sixty rats were divided  into  twelve groups 
of five rats each. Groups 1 received 5 mL/kg body weight 
distilled water. Groups 2-4, 5-7 and 8-10 were treated with 
7.5-30 mg/kg body weight doses of fractions 12, 13 and 14 
respectively. Group 11 was administered with 100 mg/kg 
body weight ASA. All treatment was done orally via an oral 
cannula. Forty five minutes after treatment in each group, 1 
mL of 2% acetic acid was injected intraperitoneally  per rat. 
Immediately after the injection of acetic acid, each rat was 
transferred into a plastic observation chamber and after a 
latency time of 10 min, the number of full writhes (a wave 
of abdominal muscle contraction followed by hind limb 
extension) was counted during a 15 min observation time.
   The percentage reduction in writhing in the treated 
groups was calculated as:
Ezenyi Ifeoma Chinwude et al./Asian Pac J Trop Biomed 2014; 4(9): 707-713710
(Mean number of writhing control− Mean number of writhing treated) × 100
Mean number of writhing control
 
    
2.8. TLC of active fractions
   Fingerprints of fractions 12, 13 and 14 were obtained by 
TLC. Samples were spotted on pre-coated silica gel plates 
(2 cm×5 cm, Merck, Darmstadt, Germany). Mobile phase 
systems used were methanol: chloroform (7:93) for fraction 
12; and methanol: chloroform (20:80) for fractions 13 and 14 
while sitosteryl glycoside was used as reference standard. 
The resolved spots were air dried, then derivatized with 10% 
H2SO4 in methanol with heating at 110
 o
C for 1 min.
2.9. High performance liquid chromatography (HPLC) 
fingerprinting 
   HPLC fingerprint was obtained for fraction 12 and a 
separate fingerprint obtained for combined fractions 13 
and 14 based on TLC and activity profile. A Shimadzu HPLC 
chromatography system consisting of Ultra-Fast LC-20AB 
prominence equipped with SIL-20AC auto-sampler; DGU-
20A3 degasser; SPD-M20A UV-diode array detector; column 
oven CTO-20AC, system controller CBM-20Alite and Windows 
LCsolution software (Shimadzu Corporation, Kyoto Japan); 
column VP-ODS 5 µm and dimensions of 150 mm伊4.6 mm. 
The chromatographic conditions included mobile phase: 
solvent A: 0.2% v/v formic acid; solvent B: acetonitrile and 
methanol (50:50); mode: linear gradient; flow rate 0.6 mL/
min; injection volume of 20 µL solution of compounds and 
fractions in methanol; detection ultraviolet 254 nm. The HPLC 
operating conditions were programmed to give the following: 
at 0.01 min, solvent B: 30%; at 15 min, solvent B: 60%; at 20 
min, solvent B: 90%; at 25 min, solvent B: 30%. Column oven 
temperature was 40 °C.  The total run time was 25 min.
2.10. Column separation and spectroscopy
   About 0.945 g quantity of fraction 12 was separated by CC 
over silica gel (2.5 cm×60 cm, 200-400 mesh size) by gradient 
elution starting with methanol: chloroform 2:98 (200 mL), 
4:96 (200 mL), 8:92 (300 mL), 10:90 (200 mL), 25:75 (200 mL) and 
100% methanol (200 mL) to collect 9 fractions based on TLC 
profiles. Sub fraction 3 was subjected to preparative TLC with 
methanol: chloroform (8:92) followed by further purification 
by CC separation (1 cm×40 cm) with isocratic elution using 
acetone: petroleum ether (20:80). This afforded 6.6 mg of 
a colourless amorphous material, which was subjected to 
spectral analyses. 
   1
H and 13C nuclear magnetic resonance (NMR) spectra were 
recorded using 400 MHz and 100 MHz Bruker FT-NMR Ultra 
Shield spectrometers. Chemical shifts were reported in 
parts per million (δ). Residual solvent peaks in respective 
deuterated solvents were used as internal reference; central 
peaks were 7.22 and 150.30 for Pyridine-d5. Electrospray 
ionization mass spectroscopy was carried out on surveyor 
MSQ (ThermoFinnigan). 
2.11. Statistical analysis
   Data were analysed using Graph Pad Prism 5.0. Results 
were expressed as mean依standard error of mean and 
subjected one way analysis of variance followed by Dunnet’s 
test for multiple comparisons. Differences between groups 
were accepted as significant at P<0.05.
3. Results 
   In the antiplasmodial assay of the gradient fractions, 
fractions 11, 12, 13 and 14 showed moderate to high potency 
against two strains of P. falciparum used, with IC50<20 µg/
mL (Table 1). These fractions had lower IC50 against the 
chloroquine resistant parasite relative to the chloroquine 
sensitive strain. Fractions 1-5, 10 and 15 did not show any 
activity at the concentrations used. Fractions 6, 7 and 8 
were moderately active only against HB3 strain, with IC50 of 
49.82, 51.5 and 52.12 µg/mL respectively, but were not active 
or had higher IC50 values against FcM29 strain, similar to 
chloroquine. The highest activity was recorded for fraction 
13 against FcM29, as no parasite growth was detected at 
the lowest concentration used (0.39 µg/mL). Fraction 13 
also exhibited maximum antiplasmodial activity against 
chloroquine sensitive HB3 strain (IC50=0.97 µg/mL), compared 
with other fractions although it was less effective than 
chloroquine (IC50=0.032 µg/mL). 
Table 1
In vitro anti-plasmodial activity of fractions against P. falciparum. 
Fractions and drugs IC50 [HB3 (µg/mL)] IC50 [FCM29 (µg/mL)]
Fraction 1 >50.000 >50.000
Fraction 2 >50.000 >50.000
Fraction 3 >50.000 >50.000
Fraction 4 >50.000 >50.000
Fraction 5 >50.000 >50.000
Fraction 6   49.820 >50.000
Fraction 7   51.500 >50.000
Fraction 8   52.120 >50.000
Fraction 9 >50.000 >50.000
Fraction 10 >50.000 >50.000
Fraction 11   17.050   10.330
Fraction 12     7.930    5.502
Fraction 13     0.970  <0.390
Fraction 14     0.990    0.890
Fraction 15 >50.000 >50.000
Chloroquine     0.032     0.090
Quinine NTa     0.040
Artemisinin NTa     0.010
Data are expressed as means of duplicate analyses.
NT
a=Not tested.
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   Table 2 showed that the fractions did not display high 
cytotoxicity against THP-1 cell line at the concentration 
tested and their IC50 values were estimated to be >100 µg/mL. 
Results in Table 3 illustrated the effect of these fractions 
on acetic acid-induced abdominal writhing. Fraction 12 
showed significant (P<0.05) activity and reduced the mean 
number of writhes by 66.67% compared to the untreated 
control group. This effect was higher than that produced 
by 100 mg/kg aspirin which inhibited writhing by 65.22%. 
Similarly, fraction 14 had significant (P<0.05) activity at 15 
and 30 mg/kg doses, although this effect was not observed 
to be dose-dependent. At the doses of fraction 13 used 
(7.5-30 mg/kg), inhibition of writhing by 43.48%-58.70% was 
statistically insignificant (P>0.05). 
Table 2
Effect of fractions (100 µg/mL) on THP-1 cell line.
Fraction % Inhibition
a
IC50 (µg/mL)
 12 2.98 >100
 13 NIb >100
 14 4.90 >100
a: % inhibition calculated based on duplicate measurements for THP-1. 
b: No inhibition.
Table 3
Peripheral anti-nociceptive activity of antiplasmodial-active fractions in 
acetic acid-induced abdominal writhing in rats.
Group Dose (mg/kg) Mean number of writhes % Reduction
Control - 9.20依1.46 -
Fraction 12   7.5 5.80依1.93 36.96
15.0 4.40依0.68 52.17
30.0  3.00依1.34a 66.67
Fraction 13  7.5 5.20依1.39 43.48
15.0 3.80依1.24 58.70
30.0 3.86依1.16 58.70
Fraction 14   7.5 8.30依1.25  9.78
 15.0 2.80依0.97a 69.52
 30.0 3.20依0.97a 65.22
ASA 100.0 3.20依1.77a 65.22
aP<0.05, significantly different from control, n=5.
 
   Further separation of the highly active antiplasmodial 
fractions led to the isolation and the identification of sterol 
glycosides and an esterified sterol glycoside. TLC of the 
fractions showed the presence of three major compounds 
in combined fractions 13 and 14, one of which had the same 
retention factor (Rf) value of 0.73 with standard sitosteryl 
glycoside marker. This was, however, not detected in 
fraction 12. Figure 1 and 2 showed the HPLC profiles of 
the fractions, which indicate their respective component 
peaks. Spectroscopic analysis of the compound isolated 
from fraction 12 revealed the presence of one sugar 
moiety, signals indicative of a steroid and fatty linkage 
in the13C NMR and DEPT spectra. Methylene at δ 63.44 in 
sugar region of 13C NMR spectrum was indicative of glucose 
esterification at C-6’. Presence of one olefinic proton at δ 
5.36 and six methyl resonances at δ 0.70 (3H, s, H-18), 0.83 
(3H, d, J=6.9 Hz, H-26), 0.85 (3H, d, J=6.81 Hz, H-27), 0.90 
(3H, t, J=7.4 Hz, H-29), 0.95 (3H, d, J=6.14 Hz, H-21) and 
1.02 (3H, s, H-19) indicated steroid to be sitosterol. Thus 
the compound was suspected to be sitosterol glucoside 
with fatty acid esterified at C-6’. Mass spectroscopy gave 
[M+Na]+at m/z 837.66 corresponding to palmitic ester. 
Thus, the compound was identified as sitosteryl-6-β-D-
glucoside-6’-palmitate after comparison of its spectra with 
Sigma Aldrich reference spectra for palmitic acid and from 
its identification in a prior report[20,21]. 
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4. Discussion
   In this study, we identified an esterified sterol glycoside 
from an antiplasmodial active fraction of P. niruri. Our 
results indicate that IC50 values of fractions 11-14 were 
lower for the chloroquine resistant parasite and higher 
for the chloroquine sensitive strain, while the reverse 
was obtained for chloroquine with IC50 value that was 
three times higher for the chloroquine resistant strain 
compared to the chloroquine sensitive strain. This implies 
that the antiplasmodial activity of these fractions may 
have been elicited through a different mechanism, unlike 
the antiplasmodial mechanism of action of chloroquine. 
Chloroquine acts against the parasite by preventing the 
detoxification of heme in the food vacuole of the parasite 
and the accumulation of this toxic metabolic product 
subsequently leading to the death of the parasite[22]. 
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Chloroquine-resistant parasites have been shown to 
circumvent the lethality of chloroquine by the rapid efflux 
of the drug from the parasite. Thus, the fractions may have 
elicited their actions via a non-heme accumulative action 
as shown by their higher activity against the chloroquine 
resistant strain. This finding is consistent with earlier report 
of Sholikhah et al. that showed a lower IC50 value of P. niruri 
methanol extract against the chloroquine resistant FCR-3 
strain, compared with its IC50 against chloroquine sensitive 
D-10 strain[14]. These findings support and favour the 
ethnomedicinal application of P. niruri preparations against 
malaria in tropical endemic areas where chloroquine-
resistant parasites are abundant. These fractions were also 
non-toxic and the report of Ramasamy et al. supports this 
observation[23]. The authors reported low cytotoxic effect 
(IC50>30 µg/mL) of P. niruri extracts against four human cell 
lines in vitro. This implies that the fractions are specific 
in their antiplasmodial actions and have a high selectivity 
index, which is a ratio of lethal to effective concentrations 
of a given test substance.
   The inhibition of abdominal writhing by the fractions 
in response to painful stimuli may be related to the 
inhibition of release and/or action of these mediators. 
This finding illustrates the anti-inflammatory activity 
of the fractions and supports the findings of an earlier 
report[10]. intraperitoneal administration of dilute acetic 
acid incites local tissue injury which prompts the release 
of chemical mediators (K+, H+, ATP and bradykinin) and 
inflammatory mediators (PGE2, pro-inflammatory cytokines) 
from inflammatory cells. These in turn trigger the release of 
mediators such as prostaglandins, serotonin and histamine 
though reaction cascades that cause sensitization of 
afferent nerve terminals and ultimately result in heightened 
response to the painful stimulus[24]. Inflammation is a 
pathophysiological reaction in response to injury, cellular 
stress or infection. The observed anti-inflammatory action 
of the fractions will be useful in the alleviation of malaria-
associated inflammation induced by pathogen-initiated 
release of activated immune effector and regulatory cells 
which infiltrate the vascular beds of diverse target organs, 
including bone marrow, spleen, brain, placenta and lungs.
   Our previous investigation on P. niruri and the report of 
Sholikhah et al. revealed that P. niruri methanol extract 
possessed higher activity than aqueous extract; thus, the 
chloroform fraction of the methanol extract was selected for 
antiplasmodial activity-guided separation in this study[14,15]. 
Previously, Subeki et al. isolated and reported the 
antiplasmodial activity of the compounds 1-O-galloyl-6-
O-luteoyl-α-D-glucose (IC50=1.4 µg/mL) and β-glucogallin 
(4.6 µg/mL) from an aqueous extract of P. niruri plant against 
chloroquine sensitive FCR-3 P. falciparum[13]. The esterified 
sterol glucoside identified presently may be employed as a 
marker compound of biological activity. Sterol glycosides 
have been found to have wide therapeutic applications 
as cardiotonic, contraceptive, anti-inflammatory and 
anticancer agents[25], and this may also account for the 
observed activity of the fraction.
   Our study reveals the presence of potent antiplasmodial 
and analgesic fractions in chloroform portion of P. niruri 
methanol extract, and the identification of sitosteryl 
glucoside palmitate as a potential chemical marker of 
activity.  
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Comments 
Background
   Malaria is the main cause of death in endemic regions 
and shows the high prevalence of resistant parasite strains 
to standard antimalarials. The search for new and no toxic 
antimalarial drugs is urgently needed.
  
Research frontiers
   The authors have screened P. niruri for its antiplasmodial 
and cytotoxic activities. Chromatographic fractionation 
of the chloroform portion of P. niruri methanolic extract 
exhibited bioactivity against P. falciparum (HB3 and FcM29) 
and low toxicity against THP-1 cell lines. Bio-guided 
assay has been conducted for the isolation and structure 
characterization of sitosteryl-6-β-D-glucoside-6’-
palmitate by 1H, 13C NMR and mass spectrometry techniques.
 
Related reports
   Many scientific reports have indicated that P. niruri 
possessed antimalarial activity both in vitro and in vivo 
as well as analgesic activity. There is controversial data 
concerning the therapeutic index. The authors’ present 
work confirmed that P. niruri is potentially safe because of 
its great cytotoxic index value.
Innovations and breakthroughs
   The authors have demonstrated that P. niruri possess good 
antimalarial activity while lacking cytotoxicity.
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Applications
   The present study has indicated the possibility of 
formulating and standardizing P. niruri as phytomedicine 
for the management of malaria in endemic areas.   
Peer review
   This is an interesting work in which the authors have 
isolated and elucidated the structure of an antiplasmodial 
phytochemical sitosteryl-6-β-D-glucoside-6’-palmitate 
by the mean of NMR spectroscopy experiments and mass 
spectrometry. Modern cell biology techniques were used 
to validate the bioactivity and the safety of the pant, thus 
justifying pharmaceutical standardization of recipes from 
this plant material.
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